Results 261 to 270 of about 297,525 (311)
Some of the next articles are maybe not open access.
Journal of Alzheimer's Disease, 2010
The worldwide costs of dementia are US$315 billion [1]. Monthly costs of Alzheimer’s disease in Spain are 1,426 per month [2]. What is the purpose, value, and usefulness of such statements? The number of Cost of Illness (CoI) studies is steadily increasing.
openaire +3 more sources
The worldwide costs of dementia are US$315 billion [1]. Monthly costs of Alzheimer’s disease in Spain are 1,426 per month [2]. What is the purpose, value, and usefulness of such statements? The number of Cost of Illness (CoI) studies is steadily increasing.
openaire +3 more sources
Cost-of-Illness in Rare Diseases
2017Cost-of-illness (COI) studies quantify the economic burden of a disease, including direct healthcare and non-healthcare costs and productivity losses. Different approaches can be adopted to evaluate the resources associated to a disease and to calculate the total costs.
Renata, Linertová +2 more
openaire +2 more sources
PharmacoEconomics, 2006
The number of cost-of-illness (COI) studies has expanded considerably over time. One outcome of this growth is that the reported COI estimates are inconsistent across studies, thereby raising concerns over the validity of the estimates and methods.
Ebere, Akobundu +3 more
openaire +2 more sources
The number of cost-of-illness (COI) studies has expanded considerably over time. One outcome of this growth is that the reported COI estimates are inconsistent across studies, thereby raising concerns over the validity of the estimates and methods.
Ebere, Akobundu +3 more
openaire +2 more sources
PharmacoEconomics, 1998
A sample of cost-of-illness (COI) studies was reviewed, which included studies for specific diseases ('specific' studies) as well as those for the entire range of diseases ('general' studies). Theoretically, COI studies may deliver suitable information for health policy and rational healthcare spending.
openaire +4 more sources
A sample of cost-of-illness (COI) studies was reviewed, which included studies for specific diseases ('specific' studies) as well as those for the entire range of diseases ('general' studies). Theoretically, COI studies may deliver suitable information for health policy and rational healthcare spending.
openaire +4 more sources
PharmacoEconomics, 2011
Cost-of-illness (COI) studies aim to assess the economic burden of health problems on the population overall, and they are conducted for an ever widening range of health conditions and geographical settings. While they attract much interest from public health advocates and healthcare policy makers, inconsistencies in the way in which they are conducted
Larg, A., Moss, J.
openaire +3 more sources
Cost-of-illness (COI) studies aim to assess the economic burden of health problems on the population overall, and they are conducted for an ever widening range of health conditions and geographical settings. While they attract much interest from public health advocates and healthcare policy makers, inconsistencies in the way in which they are conducted
Larg, A., Moss, J.
openaire +3 more sources
Nederlands tijdschrift voor geneeskunde, 1992
This study is an essential prerequisite to gain more insight into the complex relationship between public health and the costs of medical care. It offers a first tentative but comprehensive description of the total direct costs generated by all diseases in the Dutch population.
L, van Roijen +2 more
openaire +1 more source
This study is an essential prerequisite to gain more insight into the complex relationship between public health and the costs of medical care. It offers a first tentative but comprehensive description of the total direct costs generated by all diseases in the Dutch population.
L, van Roijen +2 more
openaire +1 more source
Cost‐of‐illness of patients with lymphoedema
Journal of the European Academy of Dermatology and Venereology, 2017AbstractBackgroundChronic lymphoedema is characterized by a continuous need for medical treatment, many comorbidities and impaired quality of life. In Germany, about 4.5 million patients are affected by lymphoedema. Thus, lymphoedema causes high direct and indirect costs, even more in case of complications such as erysipelas and ulcers.ObjectiveThe aim
M, Gutknecht +6 more
openaire +2 more sources
Estimating the Direct Costs of Illness
The Milbank Memorial Fund Quarterly. Health and Society, 1982about estimating the costs of illness has centered around the relative advantages and disadvantages of the two basic methodologies used or proposed-the "human capital" method as against "willingness to pay." Very briefly, the human capital approach requires estimating the direct costs of illness, i.e., the costs of prevention, detection, treatment, and
openaire +2 more sources
Cost of Illness of Crohn??s Disease
PharmacoEconomics, 2002Crohn's disease is a chronic inflammatory bowel disease of unknown aetiology which affects around 35,000 people in the UK (population 56.8 million). The potential for onset in early adult life, disease chronicity and a need for hospitalisation and surgery mean that the disease can be associated with substantial healthcare costs. Cost-of-illness studies
openaire +2 more sources
Costs of Illness in Cost-Effectiveness Analysis
PharmacoEconomics, 1994Costs of illness are an important input in cost-effectiveness analysis (CEA). Reviews of the literature have found that many CEAs are of low technical quality and fail to take account of costs of illness appropriately. The costs of illness and disease averted by an intervention, indirect costs, and medical care costs in added years of life are topics ...
openaire +2 more sources